These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38636781)

  • 121. Immunotherapy in triple-negative breast cancer.
    Katz H; Alsharedi M
    Med Oncol; 2017 Dec; 35(1):13. PubMed ID: 29255938
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer.
    Fan W; Li W; Li L; Qin M; Mao C; Yuan Z; Wang P; Chu B; Jiang Y
    Eur J Pharm Sci; 2024 Jun; 197():106767. PubMed ID: 38636781
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Epi-drugs as triple-negative breast cancer treatment.
    Idrissou M; Sanchez A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2020 Apr; 12(8):725-742. PubMed ID: 32396394
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.
    Garmpis N; Damaskos C; Garmpi A; Kalampokas E; Kalampokas T; Spartalis E; Daskalopoulou A; Valsami S; Kontos M; Nonni A; Kontzoglou K; Perrea D; Nikiteas N; Dimitroulis D
    Cancer Genomics Proteomics; 2017; 14(5):299-313. PubMed ID: 28870998
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Triple-negative breast cancer molecular subtyping and treatment progress.
    Yin L; Duan JJ; Bian XW; Yu SC
    Breast Cancer Res; 2020 Jun; 22(1):61. PubMed ID: 32517735
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Targeting triple negative breast cancer with histone deacetylase inhibitors.
    Fedele P; Orlando L; Cinieri S
    Expert Opin Investig Drugs; 2017 Nov; 26(11):1199-1206. PubMed ID: 28952409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 7.